UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): ~~March~~April 272, 2020

ALPHA-EN CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

Delaware		001-12885		95-4622429
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

28 Wells Avenue, 2nd Floor, Yonkers, New York ~~(Address of Principal Executive Offices)~~

(Address of Principal Executive Offices)

(914) 418-2000

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		ALPE		OTC Markets

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240. 12b-2).

Emerging growth company[ [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Item 87.01 ~~Other~~Regulation ~~Information~~FD.

~~Relying~~On April 2, 2020 the Company issued a letter to its stockholders. The letter is attached to this Current Report on ~~Order~~Form 8-K as Exhibit 99.1 and is incorporated herein solely for ~~Reporting~~purposes ~~Relief~~of this Item 7.01.

OnThe ~~March~~information 4,set ~~2020,~~forth ~~the~~in ~~Securities~~this ~~and~~report, ~~Exchange~~including ~~Commission~~Exhibit ~~(“SEC”)~~99.1 ~~issued~~is anfurnished ~~order~~pursuant ~~(the~~to ~~“Order”)~~Item ~~under~~7.01 ~~the Exchange~~and ~~Act~~shall ofnot ~~1934~~be ~~(the~~deemed “~~Exchange Act~~filed”~~) extending the deadlines~~ for ~~filing~~purposes ~~certain~~of ~~reports~~Section ~~made~~18 ~~under~~of the Securities Exchange Act, ~~including~~of ~~annual~~1934, ~~reports~~as onamended ~~Form~~(the ~~10-K~~“Exchange Act”), ~~for~~or ~~registrants~~otherwise subject to the ~~reporting~~liabilities ~~obligations~~ under ~~the Exchange Act~~ that ~~have been~~section, ~~particularly~~nor ~~impacted~~shall bysuch ~~the~~information ~~coronavirus~~be ~~disease~~deemed ~~2019~~incorporated ~~(“COVID-19”)~~by ~~and~~reference ~~which~~in ~~reports~~any ~~have~~ filing ~~deadlines~~under ~~between~~the ~~March~~Securities 1Act ~~and~~of ~~April 30~~1933, ~~2020.~~as ~~Alpha-En~~amended, ~~Corporation~~or (the ~~“Company”)~~Exchange ~~is relying on the Order with respect to its Annual Report on Form 10-K for the year ended December 31~~Act, ~~2019~~except ~~which~~as ~~was~~shall ~~due to~~ be ~~filed~~expressly ~~with~~set ~~the~~forth ~~SEC~~by onspecific orreference ~~before~~in ~~March~~such a ~~30, 2020~~filing.

~~The Company~~Item is relying on the Order due to the reduction in staff, suspension of in-person operations at headquarters and lab facility in Yonkers, New York, and other financial and operational concerns associated with or caused by COVID-199.01 ~~The~~Financial ~~Company’s business~~Statements operations are contracted in the greater New York city area, which is currently on “lock-down” orders or “shelter in place” recommendations, including key personnel responsible for assisting the Company in the development of its financial statements. As a result of the travel and work restrictions stemming from the COVID-19 pandemic, the Company is unable to obtain financial records that it needs from its operations to permit the Company to file a timely and accurate Annual Report on Form 10-K for its year ended December 31, 2019 by the prescribed date without undue hardship and expense to the CompanyExhibits. ~~The Company anticipates that it will be able to file its Annual Report on Form 10-K for the year ended December 31, 2019 on or before May 14, 2020.~~

~~COVID~~99.1 Letter to the Stockholders of alpha-~~19 Risk~~En ~~Factor~~Corporation dated April 2, 2020

The Company is supplementing the risk factors previously disclosed in its most recent periodic reports filed under the Securities Exchange Act of 1934 with the following risk factor:

Our financial and operating performance is adversely affected by the coronavirus pandemic.

The recent outbreak of a strain of coronavirus (COVID-19) in the U.S. has had an unfavorable impact on our business operations. Mandatory closures of businesses, imposed by the federal, state and local governments to control the spread of the virus has resulted in an extended closure of our headquarters and lab facility in Yonkers, New York, which implemented a 75% staff reduction on March 16, 2020 and closed entirely on March 23, 2020, disrupting the operations of our management, business and finance teams. If our headquarters and lab facility are not able to continue operations for an extended period, we cannot assure you that we will continue to have sufficient resources or liquidity to operate our business or that we will be able to continue to advance our technology for the production of highly-pure lithium, or continue our efforts to commercialize such technology. In addition, the COVID-19 outbreak has adversely affected the U.S. economy and financial markets, which may result in a long-term economic downturn that could negatively affect future demand for our technology or our ability to commercialize products based on that technology. The extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments which are highly uncertain and cannot be predicted at the time of the filing of this Form 8-K, but is expected to result in a material adverse impact on our business, results of operations and financial condition.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ALPHA-EN CORPORATION
	(Registrant)
Date: March 27, 2020	By:	/s/ Sam Pitroda
Date: April 2, 2020	By:	/s/ Sam Pitroda
	Name:	Sam Pitroda
	Title:	Chief Executive Officer

Filing Compare · alpha-En Corp